尊龙凯时人生就是赢(中国)官方网站尊龙凯时

尊龙凯时药业
DS Technology Platforms
Flow Chemistry Synthetic Biology & Biocatalysis Highly Potent Compound Peptide TPD/PROTAC Oligonucleotide Synthesis Crystallization & Particle Engineering Preparation & Separation
Highly Potent Compound Platform
Apeloa Highly Potent Compound Platform is dedicated to the development and manufacturing of highly potent compounds (e.g., toxins and linkers of ADC drugs) and use appropriate containment, controls, and management systems to ensure compliance with Industrial Hygiene. Apeloa has developed comprehensive EHS and safety systems combined with leading edge manufacturing suites using isolator and segregation technologies to deliver high-quality products. With the capability to safely produce a range of highly potent molecules in virtually any scale, Apeloa is an ideal partner for development and manufacturing of Registered Starting Materials (RSMs), Intermediates, and Highly Potent API (HPAPIs).
尊龙凯时药业
Team
Apeloa Highly Potent Compound Platform is led by a team of highly experienced professionals in organic synthesis, chemical engineering, process development, optimization, and scale-up. The team has successfully executed numerous highly potent compound projects, and
Services
尊龙凯时药业
尊龙凯时药业
尊龙凯时药业
尊龙凯时药业
Apeloa offers comprehensive services for HPAPI development and manufacturing, including: • Synthetic route design and selection • Process method development and demonstration • Analytical method development and pre-validation • Scale-up and commercial production
Manufacturing Facility
尊龙凯时药业
尊龙凯时药业
尊龙凯时药业
尊龙凯时药业
Our Highly Potent Compound manufacturing facilities consist of over six bays which are all separate closed systems hosting a total reactor volume of 75 m3. Three of the bays are designed to produce Registered Starting Materials (RSMs) and Intermediates rated up to OEB-4. There are several additional bays designated for the manufacture of Highly Potent Active Pharmaceutical Ingredients (HPAPIs) up to a rating of OEB-5. Our various segregated bays offer reaction, purification, filtration, washing & drying as well as some with crystallization, filtration, and grinding capabilities. Our Highly Potent API facilities are also equipped with a range of dedicated equipment to support production including distillation units, filter driers, conical driers (2000L HC22), horizontal scraper centrifuges (HC22), static tray ovens, and jet mills and hammer crusher equipment for grinding.
Equipment
Apeloa Highly Potent Compound Platform is equipped with state-of-the-art facilities, including:
  • Isolator for R&D
    Isolator for R&D
  • Isolator for scale up (50 g-500 g)
    Isolator for scale up (50 g-500 g)
  • Isolator with tray dryer
    Isolator with tray dryer
  • Tray lyophilizer (10 g - 120 g, 0.5㎡)
    Tray lyophilizer (10 g - 120 g, 0.5㎡)
  • Flask lyophilizer (0.1 g - 30 g)
    Flask lyophilizer (0.1 g - 30 g)
  • Reactor controller
    Reactor controller
  • Prep-HPLC
    Prep-HPLC
  • GC / HPLC / IR / UV
    GC / HPLC / IR / UV
尊龙凯时药业
Isolator for R&D
尊龙凯时药业
Isolator for scale up (50 g-500 g)
尊龙凯时药业
Isolator with tray dryer
尊龙凯时药业
Tray lyophilizer (10 g - 120 g, 0.5㎡)
尊龙凯时药业
Flask lyophilizer (0.1 g - 30 g)
尊龙凯时药业
Reactor controller
尊龙凯时药业
Prep-HPLC
尊龙凯时药业
GC / HPLC / IR / UV
Case: OEB 5 (Phase II, ADC-Payload & Linker)
尊龙凯时药业
Main challenges
• Complex purification process by column chromatogram in step 2 • Epimerization issue of compound E during deprotection in step 6
Achievements
  • • Develop the crystallization process to avoid the column purification.
  • • Develop the flow chem. to minimize the issue of epimerization.
  • • 1kg under non-GMP and 5 kg under GMP condition
尊龙凯时